Skip to main content
. 2017 Feb 9;2(4):610–616. doi: 10.1016/j.ekir.2017.02.004

Table 2.

Outcome parameters at various time points

15 mo
18 mo
21 mo
24 mo
TAC/GCs
(n = 35)
cCTX/GCs
(n = 35)
P value TAC/GCs
(n = 35)
cCTX/GCs
(n = 35)
P value TAC/GCs
(n = 35)
cCTX/GCs
(n = 35)
P value TAC/GCs
(n = 35)
cCTX/GCs
(n = 35)
P value
Proteinuria (g/d) 2.23 ± 3.59 (1.00–3.47) 1.10 ± 1.18 (0.70–1.51) 0.08 2.00 ± 3.50 (0.80–3.20) 1.00 ± 1.12 (0.61–1.38) 0.11 2.30 ± 3.53 (1.08–3.51) 1.04 ± 1.44 (0.54–1.54) 0.05 2.40 ± 3.51 (1.19–3.61) 1.27 ± 1.67 (0.69–1.84) 0.08
Serum albumin (g/dl) 3.48 ± 0.97 (3.15–3.81) 3.93 ± 0.54 (3.74–4.12) 0.02 3.51 ± 0.90 (3.20–3.82) 3.97 ± 0.62 (3.76–4.19) 0.01 3.48 ± 0.84 (3.18–3.77) 3.97 ± 0.56 (3.78–4.17) 0.005 3.57 ± 0.89 (3.27–3.88) 4.00 ± 0.62 (3.79–4.22) 0.02
Serum creatinine (mg/dl) 0.96 ± 0.18 (0.89–1.02) 0.93 ± 0.26 (0.84–1.02) 0.62 0.95 ± 0.17 (0.89–1.01) 0.94 ± 0.23 (0.86–1.02) 0.78 0.91 ± 0.20 (0.84–0.98) 0.93 ± 0.21 (0.86–1.00) 0.64 0.98 ± 0.25 (0.90–1.07) 0.92 ± 0.18 (0.86–0.98) 0.24

Values are means ± SDs and 95% confidence intervals.

cCTX, cyclical cyclophosphamide; GCs, glucocorticoids; TAC, tacrolimus.